- call +1-201-465-4211
- email sales@mrinsights.biz
Antineoplastic is a class of medicine to restrain or kill tumor cells in the body. It plays an important role in comprehensive cancer treatment, particularly for disseminated tumor and leukemia that cannot be treated with surgery. Most current antineoplastics work by inhibiting DNA or RNA synthesis, or even damaging the structure of DNA. Antineoplastics can be divided into CCNSA (Cell cycle nonspecific drug) and CCSA (Cell Cycle Specific agents) according to their different effect on tumor cells in different stages of generation cycles. Both of them have a killing effect on bone marrow hematopoietic stem cells and other cells with a short growth cycle, as well as an inhibiting effect on the body's immune response.
Scope of the Report:
This report focuses on the Anti-Neoplastic Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.
The worldwide market for Anti-Neoplastic Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb Company
Baxter
Boehringer Ingelheim
Bayer
Teva pharmaceutical Industries
Johnson & Johnson
Merck
Pfize
Accord Healthcare
Lundbeck
AbbVie
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Market Segment by Applications, can be divided into
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
There are 15 Chapters to deeply display the global Anti-Neoplastic Agents market.
Chapter 1, to describe Anti-Neoplastic Agents Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Neoplastic Agents, with sales, revenue, and price of Anti-Neoplastic Agents, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Neoplastic Agents, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Neoplastic Agents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Neoplastic Agents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Neoplastic Agents Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapeutic Agents
1.2.2 Biological/Immunotherapeutic Agents
1.2.3 Personalized Medicine
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Cancer Rehabilitation Centers
1.3.4 Ambulatory Surgical Centers
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Anti-Neoplastic Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hoffmann-La Roche Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Anti-Neoplastic Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb Company
2.3.1 Business Overview
2.3.2 Anti-Neoplastic Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Company Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Baxter
2.4.1 Business Overview
2.4.2 Anti-Neoplastic Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Baxter Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Anti-Neoplastic Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Anti-Neoplastic Agents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Anti-Neoplastic Agents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva pharmaceutical Industries Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Anti-Neoplastic Agents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Anti-Neoplastic Agents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfize
2.10.1 Business Overview
2.10.2 Anti-Neoplastic Agents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfize Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Accord Healthcare
2.11.1 Business Overview
2.11.2 Anti-Neoplastic Agents Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Accord Healthcare Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Lundbeck
2.12.1 Business Overview
2.12.2 Anti-Neoplastic Agents Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Lundbeck Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AbbVie
2.13.1 Business Overview
2.13.2 Anti-Neoplastic Agents Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 AbbVie Anti-Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Neoplastic Agents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Neoplastic Agents Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Neoplastic Agents Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Neoplastic Agents Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Neoplastic Agents Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Neoplastic Agents Market Analysis by Regions
4.1 Global Anti-Neoplastic Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Neoplastic Agents Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Neoplastic Agents Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
4.5 South America Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
5 North America Anti-Neoplastic Agents by Countries
5.1 North America Anti-Neoplastic Agents Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Neoplastic Agents Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Neoplastic Agents Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
6 Europe Anti-Neoplastic Agents by Countries
6.1 Europe Anti-Neoplastic Agents Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Neoplastic Agents Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Neoplastic Agents Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
6.3 UK Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
6.4 France Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Neoplastic Agents by Countries
7.1 Asia-Pacific Anti-Neoplastic Agents Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Neoplastic Agents Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Neoplastic Agents Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
7.5 India Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
8 South America Anti-Neoplastic Agents by Countries
8.1 South America Anti-Neoplastic Agents Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Neoplastic Agents Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Neoplastic Agents Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Neoplastic Agents by Countries
9.1 Middle East and Africa Anti-Neoplastic Agents Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Neoplastic Agents Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Neoplastic Agents Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Neoplastic Agents Sales and Growth Rate (2013-2018)
10 Global Anti-Neoplastic Agents Market Segment by Type
10.1 Global Anti-Neoplastic Agents Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Neoplastic Agents Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Neoplastic Agents Revenue and Market Share by Type (2013-2018)
10.2 Chemotherapeutic Agents Sales Growth and Price
10.2.1 Global Chemotherapeutic Agents Sales Growth (2013-2018)
10.2.2 Global Chemotherapeutic Agents Price (2013-2018)
10.3 Biological/Immunotherapeutic Agents Sales Growth and Price
10.3.1 Global Biological/Immunotherapeutic Agents Sales Growth (2013-2018)
10.3.2 Global Biological/Immunotherapeutic Agents Price (2013-2018)
10.4 Personalized Medicine Sales Growth and Price
10.4.1 Global Personalized Medicine Sales Growth (2013-2018)
10.4.2 Global Personalized Medicine Price (2013-2018)
11 Global Anti-Neoplastic Agents Market Segment by Application
11.1 Global Anti-Neoplastic Agents Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Cancer Rehabilitation Centers Sales Growth (2013-2018)
11.5 Ambulatory Surgical Centers Sales Growth (2013-2018)
12 Anti-Neoplastic Agents Market Forecast (2018-2023)
12.1 Global Anti-Neoplastic Agents Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Neoplastic Agents Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Neoplastic Agents Market Forecast (2018-2023)
12.2.2 Europe Anti-Neoplastic Agents Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Neoplastic Agents Market Forecast (2018-2023)
12.2.4 South America Anti-Neoplastic Agents Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Neoplastic Agents Market Forecast (2018-2023)
12.3 Anti-Neoplastic Agents Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Neoplastic Agents Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Neoplastic Agents Market Share Forecast by Type (2018-2023)
12.4 Anti-Neoplastic Agents Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Neoplastic Agents Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Neoplastic Agents Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Neoplastic Agents Picture
Table Product Specifications of Anti-Neoplastic Agents
Figure Global Sales Market Share of Anti-Neoplastic Agents by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
